Stocks Explorer
Stocks
Sectors
Search
GenSight Biologics S.A(G49N) News
Profile
Chart
News
Analysis
G49N price today
by TradingView
Date
Title
Apr 23
GenSight Biologics Annual General Meeting on May 13, 2025
Feb 12
GenSight’s Optic Neuropathy gene therapy sustains efficacy over five years
Feb 12
GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ® Gene Therapy at the Conclusion of the REFLECT Study
‹ Prev
Page
of 1
Next ›